Literature DB >> 9785131

DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.

R J Zaino1, A T Davis, B M Ohlsson-Wilhelm, V L Brunetto.   

Abstract

The identification of prognostic variables is an important aspect of managing and counseling women with endometrial adenocarcinoma. The surgical stage, age, cell type, depth of myometrial invasion, and histologic grade have all been previously demonstrated to be related to prognosis. Several reports have indicated that tumor ploidy as determined by flow cytometry with fresh or fixed cells removed from paraffin blocks of endometrial adenocarcinomas can contribute to the assessment of prognosis. To verify the significance of DNA content in endometrial adenocarcinoma, we conducted an historical cohort study on a subgroup of women from a Gynecologic Oncology Group (GOG) protocol of early clinical stage disease. Flow cytometry was performed at one facility on cells extracted from blocks obtained from several GOG member institutions. Blocks were submitted for 293 of 933 eligible patients. Ninety-two histograms were of good quality, with 55 interpreted as diploid and 37 as aneuploid. One hundred sixty-two histograms were technically suboptimal, of which 137 were considered probably diploid, 13 probably aneuploid, and 12 unacceptable due to high background noise. Of the commonly accepted prognostic variables, only depth of invasion was significantly related to the ploidy status. There was no discernable difference in survival between patients with diploid and patients with probable diploid and probable aneuploid tumor types. Incorporation of the flow cytometry data into a proportional hazards regression model adjusted for age and surgical stage revealed a significant increased risk of disease-related death (relative risk, 4.1; 95% confidence interval, 2.3 to 7.3) for patients with aneuploid tumor type as compared to patients with diploid tumor type. This study confirms the prognostic significance of ploidy determination by flow cytometry and also indicates some of the difficulties of retrospectively applying this technology to cooperative group studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785131     DOI: 10.1097/00004347-199810000-00004

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

Review 1.  Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.

Authors:  Laura Cerezo; Higinia Cárdenes; Helen Michael
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405

2.  Laminin-5 gamma2-chain expression and DNA ploidy as predictors of prognosis in endometrial carcinoma.

Authors:  C Lundgren; B Frankendal; C Silfverswärd; B Nilsson; K Tryggvason; G Auer; B Nordström
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium.

Authors:  M Pradhan; V M Abeler; H E Danielsen; B Sandstad; C G Tropé; G B Kristensen; B Å Risberg
Journal:  Ann Oncol       Date:  2011-09-30       Impact factor: 32.976

4.  DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer.

Authors:  T S Njølstad; J Trovik; T S Hveem; M L Kjæreng; W Kildal; M Pradhan; J Marcickiewicz; S Tingulstad; A C Staff; H K Haugland; R Eraker; K Oddenes; J A Rokne; J Tjugum; M S Lode; F Amant; H M Werner; H B Salvesen; H E Danielsen
Journal:  Br J Cancer       Date:  2015-04-21       Impact factor: 7.640

Review 5.  Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.

Authors:  Kouji Banno; Yuya Nogami; Iori Kisu; Megumi Yanokura; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

6.  The Correlation between EGFR Mutation Status and DNA Content of Lung Adenocarcinoma Cells in Pleural Effusion.

Authors:  Yun Du; Xiao Guo; Rui Wang; Yang Ma; Yan Zhang; Ying Liu; Lvli Dong; Juan Wu; Xiaokun Ji; Heng Wang
Journal:  J Cancer       Date:  2020-02-06       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.